Search results
Apr 22, 2024 · Lenalidomide (Revlimid) is used to treat multiple myeloma, mantle cell lymphoma, follicular lymphoma, marginal zone lymphoma, and anemia in myelodysplastic syndromes. Learn about side effects, interactions, and indications.
Lenalidomide, sold under the brand name Revlimid among others, is a medication used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes (MDS). For multiple myeloma, it is a first line treatment, and is given with dexamethasone . [8]
Lenalidomide (previously referred to as CC-5013) is an immunomodulatory drug with potent antineoplastic, anti-angiogenic, and anti-inflammatory properties. 4 It is a 4-amino-glutamyl analogue of thalidomide 3 and like thalidomide, lenalidomide exists as a racemic mixture of the active S(-) and R(+) forms. 7 However, lenalidomide is much safer ...
How does lenalidomide work? Lenalidomide works by: stopping cancer cells developing; stopping blood vessels growing in the cancer; stimulating part of the immune system to attack the cancer cells; How do you have lenalidomide? Lenalidomide comes as capsules that you take with a glass of water. You need to swallow them whole. Don’t break or ...
REVLIMID ® (lenalidomide) is a prescription medicine, used to treat adults with multiple myeloma (MM) in combination with the medicine dexamethasone, or as maintenance treatment after autologous hematopoietic stem cell transplantation (a type of stem cell transplant that uses your own stem cells).
Lenalidomide is used to treat a certain type of myelodysplastic syndrome (a group of conditions in which the bone marrow produces blood cells that are misshapen and does not produce enough healthy blood cells). Lenalidomide is also used along with dexamethasone to treat people with multiple myeloma (a type of cancer of the bone marrow).
Lenalidomide is used to treat anemia (low red blood cells) in patients with a certain type of myelodysplastic syndrome (MDS). Patients with MDS may have very low red blood cell counts and require blood transfusions.
This page contains brief information about lenalidomide and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Find patient medical information for lenalidomide oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
Indicated in combination with a rituximab product, for treatment of patients with previously treated follicular lymphoma (FL) or marginal zone lymphoma (MZL) Rituximab 375mg/m² IV qWeek in Cycle 1...
